Triethylamine → HCID 11990107, compound

HRID 1715285Notes

Reaction equation

HRID 1715285 reaction equation
[C:1]([NH:4][C:5]1[S:6][C:7]([C:11]2[N:12]=[C:13]([C:16](Cl)=[O:17])[S:14][CH:15]=2)=[C:8]([CH3:10])[N:9]=1)(=[O:3])[CH3:2].[C:19]([N:22]1[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]1)(=[O:21])[CH3:20].C(N(CC)CC)C>C1COCC1.C(Cl)Cl>[C:19]([N:22]1[CH2:27][CH2:26][N:25]([C:16]([C:13]2[S:14][CH:15]=[C:11]([C:7]3[S:6][C:5]([NH:4][C:1](=[O:3])[CH3:2])=[N:9][C:8]=3[CH3:10])[N:12]=2)=[O:17])[CH2:24][CH2:23]1)(=[O:21])[CH3:20]

Participants

6

Reactant 3

HCID 8471TriethylamineHCID 837951-AcetylpiperazineHCID 86621993HCID 86621993, compound

Product 1

HCID 11990107HCID 11990107, compoundYield 61%

Reagents, catalysts & solvents 2

HCID 6344DichloromethaneSolventHCID 8028TetrahydrofuranSolvent

Procedure

2′-Acetylamino-4′-methyl-[4,5′]bithiazolyl-2-carbonyl chloride, prepared as in Step I of Example 13, described above (160 mg, 0.53 mmol, 1 eq.), is dissolved in THF (8 ml) and DCM (4 ml). 1-Acetylpiperazine (Aldrich) (81.5 mg; 0.64 mmol; 1.20 eq.) and triethylamine (0.22 ml; 1.59 mmol; 3 eq.) are added and the mixture is stirred overnight at rt. Solvents are evaporated and the crude product is purified by preparative HPLC, affording Compound (45) as a pale yellow powder (127.9 mg; 61%). 1H NMR (DMSO-d6, 300 MHz) δ 2.04 (s, 3H), 2.13 (s, 3H), 2.49 (s, 3H), 3.57 (m, 4H), 3.65 (m, 1H), 3.70 (m, 1H), 4.25 (m, 1H), 4.35 (m, 1H), 8.01 (s, 1H), 12.16 (s, 1H). M− (ESI): 392.14; M+ (ESI): 394.15. HPLC (method A), Rt: 2.41 min (purity: 100%).

Workup

  1. customSolvents are evaporated
  2. customthe crude product is purified by preparative HPLC

Sources & evidence

ORD record
ord-65c7c9372ceb4c12b0ba9bfa241153c2
Source dataset
uspto-grants-2010_09
Patent number
US07799814B2

Reaction notes

Loading…